University of North Carolina-School of Medicine

Chapel Hill, North Carolina 27599-7190

5 studies enrolling now · 44 studies all time

What they study most

Acute Coronary Syndrome (ACS), Acute Coronary Syndromes, Anxiety Disorders, Aphasia, Apraxia of Speech, Autonomic Dysfunction, Barrett Esophagus, Barretts Esophagus With Dysplasia, Bone Avascular Necrosis, Brain Injury, Breast Cancer, Cardiovascular

Studies at this site

• Focusing on the Menopausal Transition to Improve Mid-Life Women's Health — Recruiting now
• Treatment of Inflammatory Myelitis and Optic Neuritis With Early vs Rescue Plasma Exchange (TIMELY-PLEX) — Recruiting now
• TIDES 2.0: Prevalence and Longitudinal Course of Depression, Anxiety, and Behavior Problems in Children With Cystic Fibrosis Under 12 Years of Age — Recruiting now
• A U.S. Pilot Human Investigation of RadiofrEquency Vapor Ablation System to Evaluate Safety, TOleRability, and Effectiveness for Proximal Intestinal Mucosal Ablation in Patients With Type 2 Diabetes Mellitus (RESTORE-1 Study) — Recruiting now
• Surveillance vs. Endoscopic Therapy for Barrett's Esophagus With Low-grade Dysplasia — Recruiting now
• Roflumilast or Azithromycin to Prevent COPD Exacerbations Trial — Completed
• Study of PDA-002 in Subjects With Peripheral Arterial Disease and Diabetic Foot Ulcers — Completed
• A Study Comparing the Efficacy and Safety of Polatuzumab Vedotin With Rituximab-Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab-Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Diffuse Large B-Cell Lymphoma — Completed
• INO-5401 and INO-9012 Delivered by Electroporation (EP) in Combination With Cemiplimab (REGN2810) in Newly-Diagnosed Glioblastoma (GBM) — Running, not enrolling
• The Coma Family Program (COMA-F): A Resilience Program for Caregivers of Patients With Severe Acute Brain Injury — Starting soon
• Dupilumab in Eosinophilic Gastritis — Completed
• NBTXR3 Activated by Radiotherapy for Patients With Advanced Cancers Treated With An Anti-PD-1 Therapy — Running, not enrolling
• TRANSFORM-HF: ToRsemide compArisoN With furoSemide FORManagement of Heart Failure — Completed
• Inhaled Oxytocin and HPA Axis Reactivity — Completed
• Analysis of Surgery in Patients Presenting With Stage IV Breast Cancer — Completed
• INO-5401 + INO-9012 in Combination With Atezolizumab in Locally Advanced Unresectable or Metastatic/Recurrent Urothelial Carcinoma — Completed
• Investigating Central Neurophysiologic Correlates of Non-Motor Symptoms of Parkinson's Disease — Completed
• Multi-center Clinical Study to Evaluate the C2 CryoBalloon Focal Ablation System — Running, not enrolling
• ASPIRIN: Neurodevelopmental Follow-up Trial — Completed
• Investigation of the Safety and Pharmacology of Dry Powder Inhalation of Treprostinil — Completed
• A Study of TAK-018 in Preventing the Recurrence of Crohn's Disease After Surgery — Stopped early
• Dysport® Treatment of Urinary Incontinence in Adults Subjects With Neurogenic Detrusor Overactivity (NDO) Due to Spinal Cord Injury or Multiple Sclerosis - Study 1 — Stopped early
• Safety, Tolerability and Efficacy of Molnupiravir (EIDD-2801) to Eliminate Infectious Virus Detection in Persons With COVID-19 — Completed
• A Study to Evaluate the Efficacy and Safety of VX-150 in Treating Subjects With Pain Caused by Small Fiber Neuropathy — Completed
• A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients — Completed
• Rituximab and Belimumab for Lupus Nephritis — Completed
• Evaluation of Safety & Efficacy of BIO-11006 Inhalation Solution in Patients With ARDS — Completed
• A Study of Apixaban in Patients With Atrial Fibrillation, Not Caused by a Heart Valve Problem, Who Are at Risk for Thrombosis (Blood Clots) Due to Having Had a Recent Coronary Event, Such as a Heart Attack or a Procedure to Open the Vessels of the Heart — Completed
• Tissue Expander/Implant Reconstruction: A Single-Blinded, Randomized, Controlled Trial — Completed
• Pivotal Trial of Dermagraft(R) to Treat Diabetic Foot Ulcers — Completed
• A Phase 2 Study of Cellular and Immunologic Changes in the Skin of Subjects Receiving PH-10 — Completed
• Decompression Coring Versus Conservative Therapy in Patients With Avascular Necrosis of the Hip Related to Sickle Cell Disease — Completed
• A Study of BMS-224818 (Belatacept) in Patients Who Have Undergone a Kidney Transplant and Are Currently on Stable Cyclosporine or Tacrolimus Regimen With or Without Corticosteroids — Completed
• Auditory Masking Effects on Speech Fluency in Aphasia and Apraxia of Speech — Completed
• Informing Decisions in Chronic Critical Illness: A Randomized Control Trial (RCT) — Completed
• CATIE- Schizophrenia Trial — Completed
• Phase I/II Randomized Study of Hydroxyurea With or Without Clotrimazole in Patients With Sickle Cell Anemia — Completed
• Randomized Study of Alendronate in Adult Patients With Cystic Fibrosis Related Osteoporosis — Completed
• Study of MEDI-524 (Motavizumab) for the Prophylaxis of Serious Respiratory Syncytial Virus (RSV) Disease in High-Risk Children — Completed
• Exercise Training Program to Improve Clinical Outcomes in Individuals With Congestive Heart Failure — Completed
• A Study Assessing the REG1 Anticoagulation System Compared Heparin in Subjects With Acute Coronary Syndrome — Completed
• Study the Role of Positron Emission Mammography in Pre-surgical Planning for Breast Cancer — Status unconfirmed
• Study of the Pharmacokinetics of Mycophenolate Mofetil in Patients Who Have Undergone Orthotopic Liver Transplantation — Completed
• Genetic Study of Patients With Primary Ciliary Dyskinesia — Completed